Parexel International (ma) Corporation
Location
Massachusetts
Founded
1983-02-28
Website
Risk Signals
451 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Parexel International (ma) Corporation
Live alerts from global media, monitored by Business Radar
2022-11-10 (appliedclinicaltrialsonline.com)
Mobilizing and Maintaining Clinical Trials in Midst of War
Ukraine invasion tests the resiliency and quick action of CROs and sponsors.
Read more2017-08-15 (prnewswire.com)
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of PAREXEL International Corporation - PRXL
/PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State...
Read more
2016-08-31 (prnewswire.com)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of PAREXEL International Corporation (PRXL)
/PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities PAREXEL International...
Read more2006-03-16 (outsourcing-pharma.com)
Parexel in hot water over drug trial scare
Parexel, one of the world's leading clinical research organisations is under investigation after six men in a UK drug trial being run by the company were admitted to intensive care on Tuesday.
Read more